Back to top
more

Cue Health (HLTH)

(Delayed Data from NSDQ)

$0.15 USD

0.15
287,038

0.00 (-0.34%)

Updated Apr 25, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 28.89% and 6.81%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of -21.88% and 31.46%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Augmedix, Inc. (AUGX) Soars 7.6%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Augmedix, Inc. (AUGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Cue Health Inc. (HLTH) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 3.77% and 10.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Cue Health Inc. (HLTH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

by Zacks Equity Research

Cue Health Inc. (HLTH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Cue Health Inc. (HLTH) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cue Health Inc. (HLTH) Loses -47.82% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

by Zacks Equity Research

Cue Health Inc. (HLTH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Cue Health Inc. (HLTH) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 21.82% and 19.92%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Hims & Hers Health, Inc. (HIMS) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 18.18% and 11.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Cue Health Inc. (HLTH) Upgraded to Buy: Here's Why

by Zacks Equity Research

Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Why Cue Health (HLTH) Might Surprise This Earnings Season

by Zacks Equity Research

Cue Health (HLTH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is Nobilis Health (HLTH) a Great Stock for Value Investors Right Now?

by Zacks Equity Research

Nobilis Health (HLTH) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.

    Health Insurance Stock Outlook - January 2018

    by Zacks Equity Research

    Rapid evolution is being witnessed in the health insurance industry as the players are taking concerted efforts to transform themselves into comprehensive health care providers from their earlier role of traditional payers.

      Sejuti Banerjea headshot

      5 HMO Stocks to Continue Rewarding Investors

      by Sejuti Banerjea

      Here are five Buy-rated HMO stocks that should be in your portfolio.

        Top Ranked Value Stocks to Buy for July 17th

        by Zacks Equity Research

        Here are three stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, July 17th:

          Top Ranked Growth Stocks to Buy for July 17th

          by Zacks Equity Research

          Here are three stocks with Zacks Rank #1 (Strong Buy) and strong growth characteristics for investors to consider today, July 17th:

            Top Ranked Value Stocks to Buy for July 12th

            by Zacks Equity Research

            Here are three stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, July 12th:

              Top Ranked Growth Stocks to Buy for July 12th

              by Zacks Equity Research

              Here are three stocks with Zacks Rank #1 (Strong Buy) and strong growth characteristics for investors to consider today, July 12th:

                The Zacks Analyst Blog Highlights: Nobilis Health, Extended Stay America, SYNNEX, Citizens Financial Group and W&T Offshore

                by Zacks Equity Research

                The Zacks Analyst Blog Highlights: Nobilis Health, Extended Stay America, SYNNEX, Citizens Financial Group and W&T Offshore

                  Top Ranked Growth Stocks to Buy for July 11th

                  by Zacks Equity Research

                  Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 11th:

                    Advisory Board (ABCO) in Focus: Stock Moves 5.4% Higher

                    by Zacks Equity Research

                    Advisory Board (ABCO) was a big mover last session, as the company saw its shares rise over 5% on the day.

                      Tirthankar Chakraborty headshot

                      US Job Market Roars Back to Life: Top 5 Gainers

                      by Tirthankar Chakraborty

                      The U.S. economy created 222,000 new jobs in June, the second largest addition in the year, while hiring was also stronger in May and April than previously reported.

                        Top Ranked Value Stocks to Buy for July 10th

                        by Zacks Equity Research

                        Here are four stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, July 10th:

                          Top Ranked Growth Stocks to Buy for July 6th

                          by Zacks Equity Research

                          Here are four stocks with Zacks Rank #1 (Strong Buy) and strong growth characteristics for investors to consider today, July 6th:

                            Top Ranked Value Stocks to Buy for July 6th

                            by Zacks Equity Research

                            Here are three stocks with Zacks Rank #1 (Strong Buy) and strong value characteristics for investors to consider today, July 6th: